佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

【FINTEC 0150 交流专区】(前名 ASIABIO)

  [复制链接]
发表于 2-3-2014 03:06 AM | 显示全部楼层
推动绿色项目 亚洲生化冀业绩转好

财经新闻 财经  2014-03-01 12:06
(吉隆坡28日讯)亚洲生化(ASIABIO,0150,创业板)执行董事陈石义认为,在推动更多绿色相关项目之际,下财年业绩预计会转好。

亚洲生化截至2013年10月31日财政年第3季的亏损,因营运成本增加而扩大至190万8000令吉。同期营业额则扬181%,报77万令吉。

首9个月而言,亏损则是收窄至91万4000令吉;营业额扩大4.9%,至143万4000令吉。

陈石义在结束股东特别大会后对《南洋商报》说,来年业绩料比去年好。

“我们并非一家贸易营销公司,我们是一家科技投资公司。

很多的投资都是无法马上看见回报,除了需要投下资金,也必须耐心等候。

“但是,我对公司接下来的前景,以及手上的投资回酬很有信心。”

亚洲生化在2月20日宣布,联号公司Nexfuel有限公司与美国洁能科技公司CoolPlanet合作,在马投资7000万美元(2亿3090万令吉)打造绿能炼油厂,这也是该公司首度授权予美国以外的公司。

绿能炼油厂 后年投产

陈石义表示:“虽然这项合作计划未能在一两年内看见回报。不过,一旦在2016年竣工投产后,相信可改变全球的汽油业,进而推动公司增长。”
他也披露,已为上述厂房选定数个理想地点。

“我们要在物流输送方便的地区设厂,希望选择靠近码头的地方,或者在彭亨和柔佛地区。”

亚洲生化股东也在今天的股东特别大会上,批准附加股和送凭单计划,集资最高4202万令吉,作为日后投资和营运资本。【南洋网财经】




回复

使用道具 举报


ADVERTISEMENT

发表于 14-3-2014 02:29 AM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

EX-date
26/03/2014
Entitlement date
28/03/2014
Entitlement time
05:00:00 PM
Entitlement subject
Rights Issue
Entitlement description
RENOUNCEABLE RIGHTS ISSUE OF UP TO 420,200,000 NEW ORDINARY SHARES OF RM0.10 EACH IN ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO")(“RIGHTS SHARES”) TOGETHER WITH UP TO 420,200,000 FREE DETACHABLE WARRANTS (“WARRANTS”) ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY ONE (1) EXISTING ORDINARY SHARE OF RM0.10 EACH IN ASIABIO TOGETHER WITH ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED IN ASIABIO AT 5.00 P.M. ON 28 MARCH 2014 AT AN ISSUE PRICE OF RM0.10 PER RIGHTS
SHARE PAYABLE IN FULL UPON ACCEPTANCE ("RIGHTS ISSUE WITH WARRANTS")
Period of interest payment
to
Financial Year End

Share transfer book & register of members will be
to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no
Tricor Investor Services Sdn Bhd

Level 17, The Gardens North Tower
Mid Valley City
Lingkaran Syed Putra
59200 Kuala Lumpur

Telephone number: 03-2264 3883
Payment date

a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers
28/03/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit

c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
420200000
Entitlement indicator
Ratio
Ratio
1 : 1
Rights Issues/Offer Price
0.1


Despatch Date
01/04/2014
Date for commencement of trading of the rights
31/03/2014
Date for despatch of abridged prospectus and subscription forms
01/04/2014
Date for cessation of trading of the rights
07/04/2014
Date for announcement of final subscription result and basis of allotment of excess Rights Securities
21/04/2014
Listing date of the Rights Securities
28/04/2014

Last date and time forDateTime
Sale of provisional allotment of rights04/04/2014
at
05:00:00 PM
Transfer of provisional allotment of rights09/04/2014
at
04:00:00 PM
Acceptance and payment14/04/2014
at
05:00:00 PM
Excess share application and payment14/04/2014
at
05:00:00 PM

回复

使用道具 举报

发表于 21-3-2014 04:19 PM | 显示全部楼层
icy97 发表于 14-3-2014 02:29 AM

这个股可以买进吗?

点评

http://klse.i3investor.com/servlets/stk/fin/0150.jsp  发表于 21-3-2014 05:50 PM
http://www.malaysiastock.biz/Corporate-Infomation.aspx?type=A&value=A&source=M&securityCode=0150  发表于 21-3-2014 05:49 PM
如你有去了解这家公司+了解它的财务报告,就会晓得是否可买进。。  发表于 21-3-2014 05:49 PM
回复

使用道具 举报

发表于 21-3-2014 05:58 PM | 显示全部楼层
chloetee820 发表于 21-3-2014 04:19 PM
这个股可以买进吗?

oh 好的,不明白在问你
回复

使用道具 举报

发表于 29-3-2014 05:47 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/01/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/01/2014
31/01/2013
31/01/2014
31/01/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
2,266
946
3,700
2,313
2Profit/(loss) before tax
267
-2,090
-709
-4,317
3Profit/(loss) for the period
267
-2,161
-710
-4,403
4Profit/(loss) attributable to ordinary equity holders of the parent
269
-2,161
-645
-4,394
5Basic earnings/(loss) per share (Subunit)
0.07
-0.57
-0.16
-1.15
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0559
0.0531

回复

使用道具 举报

发表于 12-4-2014 05:23 PM | 显示全部楼层
ASIABIO - OR (0150OR)为什么没了?

点评

如现还特有-OR+没付款认购。。那特有的只是张废票,什么都没有。。  发表于 12-4-2014 05:58 PM
如你是特有-OR+还未及出售,就得14号最后付款期限,付每股0.10认购价行使OR转换母股。。就这样。。详情就在楼上的告示。。  发表于 12-4-2014 05:57 PM
那是一定的,-OR这是个认购附加股的权益(俗称白表格)。。上市交易期限短-大致只有一个星期,之后就会停止交易+除牌。。  发表于 12-4-2014 05:57 PM
回复

使用道具 举报

Follow Us
发表于 13-4-2014 12:14 PM | 显示全部楼层
kong_88 发表于 12-4-2014 05:23 PM
ASIABIO - OR (0150OR)为什么没了?

版主,谢谢你的解释~

点评

客气。。  发表于 13-4-2014 12:55 PM
回复

使用道具 举报

发表于 18-4-2014 03:03 AM | 显示全部楼层
亚洲生物科技 售燃料予宏国能源

财经 2014年4月17日
(吉隆坡17日讯)亚洲生物能源科技(ASIABIO,0150,创业板)透过附属公司,Nexfuel有限公司与与新加坡原油和精炼產品贸易公司--宏国能源(Concord ENERGY),签署生物燃料採购协议,以发展在大马的燃料生產厂。        

宏国能源將买入所有由亚洲生物能源联號公司--NexFuel旗下公司利用美国Cool Planet能源系统公司所生產的生物燃料。

根据该协议,宏国能源將购买全数由绿能炼油厂生產的生物燃料產品。这项协议將会从第一家绿能炼油厂的首批交易开始生效,为期6年。

一旦绿能炼油厂开始运作,预计能为该公司作出正面的盈利贡献。

Nexfuel在2014年2月20日与美国Cool Planet签订厂房建设合约(Plant Construction Agreement),並授权Nexfuel在马来西亚使用其科技发展燃料製造厂房。

亚洲生物能源科技今日大热走高,闭市上涨1仙或10.53%,至0.105令吉,成交量达1亿3717万股,是今日第2大热门股。【东方网财经】

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”)
• SIGNING OF BIOFUELS OFFTAKE AGREEMENT BETWEEN NEXFUEL LIMITED (“NEXFUEL”) AND CONCORD ENERGY PTE. LTD. (“CONCORD”)
1. Introduction
The Board of Directors of ABT is pleased to announce that its associated company, Nexfuel has on 16 April 2014 entered into a Biofuels Offtake Agreement (“Agreement”) with Concord for the offtake sale of all of the biofuels products to be produced by one or more subsidiaries to be established under Nexfuel using the technology developed by Cool Planet Energy Systems, Inc. (“Cool Planet”) (each, a “Project Company”).

The Agreement is signed following the Plant Construction agreement which was previously signed between Nexfuel and Cool Planet on 20 February 2014, giving Nexfuel the licensing rights to Cool Planet’s technology to develop fuel production plants in Malaysia (“Cool Planet Technology”).  Nexfuel intends to establish via the Project Companies, one or more of such fuel production plants with the first targeted to be completed by year 2016.

2. Information on Concord
From its inception in 1998, Concord has grown to become one of Singapore and South East Asia’s leading crude oil and refined products trading companies. Today, based in Singapore, Concord Energy Group is an organization that is constantly developing new aspects of its business as it evolves into an integrated, asset-based energy company.

Headquartered in Singapore, Concord has offices in Dubai, Indonesia, Malaysia, Switzerland, China and United Kingdom.

3. Information on Nexfuel
Nexfuel is a company incorporated in Labuan, Malaysia with a paid up share capital of USD125,000 comprising 125,000 ordinary shares of USD1.00 each and is involved in provision of biomass processing and phytonutrients processing technologies. Nexfuel is a 20% associated company of ABT.

4. Information on Cool Planet
Cool Planet is a proprietor of a fuel processing technology that is able to convert non-food biomass into high-octane, dropin biofuels (gasoline). Cool Planet’s conversion process also produces a by-product called biochar, a solid material that is obtained through the carbonization of the biomass. Biochar, when blended with soil, has the unique ability to vastly improve plant harvests while reducing the amount of water and fertilizer needed. The process can be carbon negative, capable of removing over 100 percent of the carbon footprint for every gallon used, thus reversing the consequences of the use of fossil fuels.

Cool Planet’s technology has a broad portfolio of pending and granted patents.

5. Salient Features of the Agreement
Salient features of the Agreement include the following:-

a) In accordance to the Agreement, Nexfuel will cause each Project Company to sell, and the Buyer will purchase, all of the biofuel products produced at its Facility.

b) This Agreement will be effective as of the Effective Date and, without prejudice to terms relating to the early termination of this Agreement, shall endure until the sixth (6th) anniversary of the date of completion of the first delivery of Product from the first Facility of the first Project Company.

c) The pricing of which is to be referenced to the monthly average of mid daily quotations as published in Platts Asia Pacific / Arab Gulf Marketscan under the heading ‘Singapore’ (“Platts Singapore”).

d) Project Company will provide Buyer, on the Commencement of Production and by the 20th day of each calendar month thereafter, a rolling schedule for the following twelve (12) months specifying the amount of each Product that Project Company anticipates, in good faith, delivering to Buyer from the Facility for each month of that twelve (12) month period.

e) The grade and specifications of the Product delivered shall be determined by reference to the results of sampling and analysis of the Product carried out by an Inspector, appointed and paid for jointly by the Project Company and the Buyer.

f) The Agreement and its construction, validity and performance and any non-contractual obligations arising from or connected with it shall be governed by the laws of England and Wales to the exclusion of any other law. For the avoidance of doubt, the United Nations Convention on Contracts for the International Sale of Goods of Vienna, 11 April 1980, and any law enacting or giving force to the same or any parts of it, shall not apply to the Agreement.

The definitions used in this section are as follows:-

Buyer” means Concord or a nominated Affiliate of Concord;

Commencement of Production” means, in respect of a specific Facility, the date on which the Project Company, acting in good faith, notifies the Buyer that commissioning and testing of the Facility has been successfully completed and commercial production of one or more Products has commenced at the Facility or, in the absence of any such notification, the first date by which the total aggregated amount of Product produced at the Facility is equal to or greater than the minimum delivery amount as specified in the Agreement for the Facility;

Effective Date” means the date on which the Agreement is signed by both parties;

Facility” means any and all facilities of a specific Project Company that are located in Malaysia, whether existing now or in the future, and at which Products are produced using the Cool Planet Technology;

Products” means the products identified as the distilled blend stock, raw blend stock (which includes all biofuel products other than distilled blend stock that are in the opinion of the Buyer suitable to be marketed for sale in the gasoline market) and other useful products (which includes all biofuel products, other than distilled blend stock or raw blend stock, such as benzene, jet/kerosene/diesel blend stocks, and lubricant blend stocks), produced at any Facilities that are in the opinion of the Buyer suitable to be marketed for sale in the refined petroleum products market.

6. Effects of the Agreement
The Agreement is not expected to have any material effect on the earnings per share of ABT Group for the financial year ending 31 January 2015, share capital, major shareholders’ shareholdings, net assets per share, gearing and dividend policy of ABT Group. Nonetheless, the Agreement is expected to contribute positively to the future earnings of the Company once the Project Companies are in place.

There are no liabilities, including contingent liabilities or guarantees, expected to be assumed by ABT from the Agreement.

7. Approvals Required
The Agreement is not subject to approval of the shareholders of ABT and relevant authorities.

8. Directors’ and Major Shareholders’ Interest
None of the Directors and major shareholders of ABT and person(s) connected to them have any direct or indirect interest in the Agreement.

9. Statement by Board
The Board of Directors of ABT is of the opinion that the Agreement is in the best interest of ABT.

A copy of the Agreement is available for inspection at the registered office of ABT during normal business hours from Monday to Friday (except public holidays) at B-11-10, Level 11 Megan Avenue II, Jalan Yap Kwan Seng, 50450 Kuala Lumpur for a period of three (3) months from the date of this announcement.

This announcement is dated 17 April 2014.
本帖最后由 icy97 于 18-4-2014 03:42 AM 编辑

回复

使用道具 举报


ADVERTISEMENT

发表于 19-4-2014 04:54 AM | 显示全部楼层
亞洲生物能源附加股超額認購

財經20 Apr 2014 15:19
(吉隆坡20日訊)亞洲生物能源(ASIABIO,0150,創業板貿易股)附加股送憑單計劃,獲得108.06%認購率。

亞洲生物能源在文告指出,上述附加股總數達4億2020萬股,發售价為每股10仙,預計本月28日于大馬交易所創業板掛牌。

亞洲生物能源執行董事呂金龍在文告中指出:“附加股認購率令人鼓舞,證明股東們對我們的商業前景和經營模式充滿信心。”

“身為一家科技技術研發公司,我們著重于開發与培育新的商業點子。透過合适的人際交涉、科技与金融專業知識,我們相信有能力實踐具有潛力的業務概念。”

在這項企業活動下,每持1股現有股的股東,將可認購1股附加股,發售高達4億2020萬股附加股。該公司也以每持1股附加股,配送1憑單的比例,發送4億2020萬憑單。

上述附加股活動將籌集4202萬令吉,其中4102萬令吉將用作技術研發的開銷。【中国报财经】

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)

RENOUNCEABLE RIGHTS ISSUE OF 420,200,000 NEW ORDINARY SHARES OF RM0.10 EACH IN ASIABIO (“RIGHTS SHARES”) TOGETHER WITH 420,200,000 FREE DETACHABLE WARRANTS (“WARRANTS”) ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY ONE (1) EXISTING ORDINARY SHARE OF RM0.10 EACH IN ASIABIO TOGETHER WITH ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED IN ASIABIO AT 5.00 P.M. ON 28 MARCH 2014 AT AN ISSUE PRICE OF RM0.10 PER RIGHTS SHARE PAYABLE IN FULL UPON ACCEPTANCE (“RIGHTS ISSUE WITH WARRANTS”)
(All abbreviations used in this announcement are defined in the announcement dated 23 September 2013)

On behalf of the Company, M&A Securities is pleased to announce that at the close of acceptance, excess application and payment for the Rights Issue with Warrants as at 5.00 p.m. on 14 April 2014 (“Closing Date”), ASIABIO received valid acceptances and excess applications for a total of 454,071,932 Rights Shares. This represents a subscription level of 108.06% of the total number of Rights Shares available under the Rights Issue with Warrants.

Details of valid acceptances and excess applications received as at the Closing Date are as follows:


No. of Rights Shares

% of total issue size

Total valid acceptances

197,894,294

47.09

Total valid excess applications

256,177,638

60.97

Total valid acceptances and excess applications

454,071,932

108.06

Total Rights Shares available for subscription

420,200,000

100.00

Total over subscribed Rights Shares

33,871,932

8.06

As the acceptances and excess applications received exceeded the issue size of 420,200,000 Rights Shares, the issue size of the Rights Issue with Warrants shall be based on the issue size of 420,200,000 Rights Shares and 420,200,000 Warrants.

The Rights Shares and Warrants are expected to be listed on the ACE Market of Bursa Malaysia Securities Berhad on 28 April 2014.

This announcement is dated 18 April 2014.

本帖最后由 icy97 于 21-4-2014 02:19 AM 编辑

回复

使用道具 举报

发表于 24-4-2014 03:51 AM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Instrument Type
Warrants
Description
Warrants 2014/2024 issued pursuant to a renounceable rights issue of warrants (“Warrants”)
Listing Date
28/04/2014
Issue Date
22/04/2014
Issue/ Ask Price
Not Applicable
Issue Size Indicator
Unit
Issue Size in Unit
420,200,000
Maturity Date
19/04/2024
Revised Maturity Date
Exercise/ Conversion Period
10.00Year(s)
Revised Exercise/ Conversion Period
Exercise/Strike/Conversion Price
MYR 0.1000
Revised Exercise/Strike/Conversion Price
Exercise/ Conversion Ratio
1
Revised Exercise/ Conversion Ratio
Mode of satisfaction of Exercise/ Conversion price
Cash
Settlement Type/ Convertible into
Physical (Shares)

Remarks :
The Warrants may be exercised any time during the tenure of the Warrants of ten (10) years including and commencing from the issue date of the Warrants and ending at 5.00 p.m. on the Expiry Date (being a date being ten (10) years from and including the date of issue of the Warrants, provided that if such day falls on a day which is not a market day, then on the preceding market day). Each Warrant carries the entitlement to subscribe for one (1) new ordinary share of RM0.10 each in Asia Bioenergy Technologies Berhad ("ASIABIO" or "Company") at the Exercise Price which shall be satisfied fully in cash and shall be subject to adjustments in accordance with the Deed Poll.

Subject to the provision in the Deed Poll, the Exercise Price and the number of Warrants held by each Warrant holder shall be adjusted by the Board of Directors of ASIABIO in consultation with the adviser and certification of the external auditors, in the event of alteration to the share capital of the Company.



Announcement Info
Company NameASIA BIOENERGY TECHNOLOGIES BERHAD (ACE Market)
Stock NameASIABIO-WA   
Date Announced23 Apr 2014  
CategoryListing Information & Profile
Reference NoOS-140414-137AF


回复

使用道具 举报

发表于 25-4-2014 03:37 AM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

LISTING'S CIRCULAR NO. L/Q : 70365 OF 2014

Kindly be advised that ASIABIO's:-

(i)        additional 420,200,000 Rights Shares issued pursuant to the Rights Issue with Warrants will be granted listing and quotation with effect from 9.00 a.m., Monday, 28 April 2014; and

(ii)        420,200,000 Warrants issued pursuant to the Rights Issue with Warrants will be admitted to the Official List of Bursa Securities and the listing and quotation of these Warrants on the ACE Market, will be granted with effect from 9.00 a.m., Monday, 28 April 2014.

The Stock Short Name, Stock Number and ISIN Code of the Warrants is as follows:-

Particulars
Warrants
Stock Short Name
ASIABIO-WA
Stock Number
0150WA
ISIN Code
MYQ0150WAY44



回复

使用道具 举报

发表于 25-4-2014 04:22 AM | 显示全部楼层
Notice of Person Ceasing (29C)
ASIA BIOENERGY TECHNOLOGIES BERHAD

Particulars of substantial Securities Holder
Name
CPE Growth Capital Limited
Address
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
NRIC/Passport No/Company No.
1709460
Nationality/Country of incorporation
British Virgin Islands
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Date of cessation
14/04/2014
Name & address of registered holder
CPE Growth Capital Limited
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
Currency
Malaysian Ringgit (MYR)
Number of securities disposed
50,000,000
Price Transacted ($$)

Circumstances by reason of which a person ceases to be a substantial securities Holder
Disposal of shares
Nature of interest
Direct
Date of notice
24/04/2014


Notice of Interest Sub. S-hldr (29A)
Particulars of Substantial Securities Holder
Name
CPE Growth Capital Limited
Address
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
NRIC/Passport No/Company No.
1709460
Nationality/Country of incorporation
British Virgin Islands
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Name & address of registered holder
CPE Growth Capital Limited
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
Date interest acquired & no of securities acquired
Currency
Malaysian Ringgit (MYR)
Date interest acquired
22/04/2014
No of securities
82,153,000
Circumstances by reason of which Securities Holder has interest
Subscription to Rights Issue Shares
Nature of interest
Direct
Price Transacted ($$)

Total no of securities after change
Direct (units)
82,153,000
Direct (%)
9.78
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Date of notice
24/04/2014
回复

使用道具 举报

发表于 28-4-2014 09:51 PM | 显示全部楼层
RM 0.005 的 ASIABIO-WA 要如何得到?是不是要拥有母股,后再买入 附加股 , 最后 才分到?
假设 母股 8 仙, 附加股 是不是要 10仙? 是不是一定会成功分到 WA?

点评

ex-date前就特有票的股东就会分配到认购附加股的权益-OR,再付款每股0.10行使它就会再分配到免费凭单。。或当时候在市场买进-OR再付款行使+认购,同样也会分配到。。就这样。。  发表于 28-4-2014 10:36 PM
你所指免费获得-WA,是的,就如你所知就是得透过认购附加股-发售价为每股0.10免费获得。。  发表于 28-4-2014 10:33 PM
回复

使用道具 举报

发表于 9-5-2014 04:02 AM | 显示全部楼层
Name
Acritaz Holdings Sdn Bhd
Address
A-3A-09 Oasis Ara Damansara
2 Jalan PJU 1A/7A
47301 Petaling Jaya
NRIC/Passport No/Company No.
736665-T
Nationality/Country of incorporation
Malaysia
Descriptions (Class & nominal value)
1. Ordinary Shares of RM0.10 each
2. Warrants
Name & address of registered holder
Acritaz Holdings Sdn Bhd
A-3A-09 Oasis Ara Damansara
2 Jalan PJU 1A/7A
47301 Petaling Jaya
Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Others28/04/2014
25,077,250

Others28/04/2014
25,077,250


Description of other type of transaction
Rights Issue with free detachable warrants
Circumstances by reason of which change has occurred
1. 25,077,250 - Acceptance of Rights Issue Shares
2. 25,077,250 - Acceptance of Free Detachable Warrants

(Item 2 is deemed interest pursuant to section 6A of the Companies Act, 1965)
Nature of interest
Direct interest
Direct (units)
50,154,500
Direct (%)
5.97
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
50,154,500
Date of notice
06/05/2014


Name
CPE Growth Capital Limited
Address
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
NRIC/Passport No/Company No.
1709460
Nationality/Country of incorporation
British Virgin Islands
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Name & address of registered holder
CPE Growth Capital Limited
Trident Chambers P.O. Box
146, Road Town, Tortola
British Virgin Islands
Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired07/05/2014
4,847,000


Circumstances by reason of which change has occurred
Open Market Acquisition
Nature of interest
Direct
Direct (units)
87,000,000
Direct (%)
10.35
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
87,000,000
Date of notice
08/05/2014
回复

使用道具 举报

发表于 18-5-2014 02:30 PM | 显示全部楼层
any comments for this ASIABIO recently?
回复

使用道具 举报

发表于 5-6-2014 03:30 PM | 显示全部楼层
它的股价没有多大的惊喜。。一直保持在0.085-0.09。。
回复

使用道具 举报


ADVERTISEMENT

发表于 19-6-2014 07:44 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")
• SIGNING OF MEMORANDUM OF AGREEMENT BETWEEN NEXFUEL SDN BHD ("NEXFUEL") AND MALAYSIAN PALM OIL BOARD ("MPOB")
The details of the announcement is attached herein.

This announcement is dated 18 June 2014.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/1659217
Attachments

回复

使用道具 举报

发表于 21-6-2014 01:26 AM | 显示全部楼层
亚洲生化首季净利挫79%

财经新闻 财经  2014-06-22 11:24
(吉隆坡21日讯)亚洲生化(ASIABIO,0150,创业板)截至4月杪首季净利挫79.11%,报48万9000令吉,或每股0.12仙。

相比上财年同期,亚洲生化净利报234万1000令吉。

亚洲生化营业额则从5万2000令吉,上扬155.76%至13万3000令吉。

该公司表示,在首季末完成的附加股活动所产生费用及Graphene Nanochem股份减值,拖累获利能力。

接下来,亚洲生化将专注在高科技,尤其是绿色相关技术。【南洋网财经】

SUMMARY OF KEY FINANCIAL INFORMATION
30/04/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/04/2014
30/04/2013
30/04/2014
30/04/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
133
52
133
52
2Profit/(loss) before tax
469
2,315
469
2,315
3Profit/(loss) for the period
469
2,315
469
2,315
4Profit/(loss) attributable to ordinary equity holders of the parent
489
2,341
489
2,341
5Basic earnings/(loss) per share (Subunit)
0.12
0.61
0.12
0.61
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0785
0.0559

本帖最后由 icy97 于 23-6-2014 12:41 AM 编辑

回复

使用道具 举报

发表于 25-7-2014 01:00 AM | 显示全部楼层
亞洲生物能源冀轉盈

2014-07-24 11:41      
(吉隆坡23日訊)亞洲生物能源(ASIABIO,0150,創業板貿服組)積極重組,未來將重點開發綠色科技業務,希望2015財政年可以轉虧為盈。

亞洲生物能源執行董事陳石義今日在股東大會後表示,早前以1配1發行附加股所籌獲的4千200萬令吉,將會用以開發木屑及木料再生能源、微生物菌培皿、太陽能及循環能源等綠色項目。

談及公司2015年的展望時,陳石義表示,近期與大馬油棕局在柔佛共同開發的油棕木料再生計劃以及在彭亨建設的微生物菌培養科技計劃,有望能夠在年內增長,希望藉此增加2015財政年收益。

陳石義指出,亞洲生物能源做為一家科技孵化基金公司,通常貫徹中長期投資方針,從尋找項目到開發至少用上3年的時間,至於投資的回酬則可能會是5年或以上。

不過,他接著說,目前公司不排除會尋找或直接投資中短期項目,比如回酬較快的經濟作物業務等。

詢及未來的業務,他表示,亞洲生物能源會注重綠色及環保業務,投資重心會放在大馬,並考慮投資海外市場。

至今,亞洲生物能源投資項目總值為1千500萬令吉。(星洲日報/財經)
回复

使用道具 举报

发表于 2-8-2014 03:52 AM | 显示全部楼层
亚洲生化307万 认购VSolar 9.09%

财经新闻 财经  2014-08-02 11:35
(吉隆坡1日讯)亚洲生化(ASIABIO,0150,创业板)通过私下配售方式,以307万4940令吉,认购VSolar集团(VSOLAR,0066,创业板)9.09%股权。

亚洲生化向马交所报备,子公司亚洲生化资本公司,以每股12仙认购VSolar集团的2562万4500股。

亚洲生化指出,认购VSolar集团股权,是配合亚洲生化要投资再生能源业务的决定。

公司相信,太阳能将成为全球最快速增长的再生能源,而且我国政府把再生能源加入产电原料中,意味领域长期展望良好。

VSolar集团的前身为捷径方案(FASTRAK)。

VSolar集团今年1月获得股东批准,多元化业务至再生能源领域。【南洋网财经】

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”)
• SUBSCRIPTION OF PLACEMENT SHARES IN VSOLAR GROUP BERHAD (FORMERLY KNOWN AS FAST TRACK SOLUTION HOLDINGS BERHAD) (“VSOLAR”)
The details of the announcement is attached herein.

This announcement is dated 1 August 2014.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/1700673
Attachments

本帖最后由 icy97 于 3-8-2014 01:05 AM 编辑

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 26-4-2024 11:15 AM , Processed in 0.105076 second(s), 23 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表